| Also known as |
Olanzapine |
| Blood pressure |
May cause orthostatic hypotension |
| Chemical name |
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine |
| Dosage (medical) |
Typically 5-20 mg/day, adjusted based on patient response and condition |
| Dosage (sports) |
Not applicable |
| Effects |
Antipsychotic, mood stabilizing, reduction in agitation and hallucinations |
| Formula |
C17H20N4S |
| Half-life |
Approximately 30 hours |
| Hepatotoxicity |
Rare, but possible |
| Lab Test |
Monitoring of liver enzymes and metabolic indicators may be required |
| Main action |
Antipsychotic |
| Side effects |
Weight gain, sedation, dry mouth, restlessness, elevated blood glucose levels |
| Storage conditions |
Store at room temperature, away from moisture and heat |
| Strength |
50 mg |
| Substance class |
Thienobenzodiazepine |
| Trade name |
Zyprexa |
| Use in sports |
None |
| Water Retention |
Minimal |
| Manufacturer |
Pharmaceutical |
